Back to mobile site

TransMedics Group (TMDX) Reiterated at Hold by Stifel Post ATC Meeting

June 26, 2026 7:53 AM EDT Send to a Friend
Stifel analyst Thomas Stephan reiterated a Hold rating and $80.00 price target on TransMedics Group (NASDAQ: TMDX).The analyst commented, "This ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login